An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
Anne Brédart(Institut Curie), Neil K. Aaronson(The Netherlands Cancer Institute), S Schraub(Hôpital Privé Jean Mermo), Marcus Mehlitz(Krankenhaus der Barmherzigen Brüder Trier), Juan Ignacio Arrarás, Thierry Conroy(Inserm), Fabio Efficace(Fondazione Gimema Onlus), C Rodary(Institut Gustave Roussy), Corneel Coens(European Organisation for Research and Treatment of Cancer), Anna Costantini(Azienda Ospedaliera Sant'Andrea), Florence Joly(Centre François Baclesse), Orhan Sezer(Charité - Universitätsmedizin Berlin), Massimo Costantini(Unknown), Jane Blazeby(University Hospitals Bristol NHS Foundation Trust), Eva Hammerlid(Sahlgrenska University Hospital), Wei‐Chu Chie(National Taiwan University), Andrew Bottomley(European Organisation for Research and Treatment of Cancer), Darius Razavi(Institut Jules Bordet), Sara D’Haese(European Organisation for Research and Treatment of Cancer), Magdalena Bielska‐Lasota(Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy)
Cited by 241
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k